Definium Therapeutics, Inc. (DFTX) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $107.77M | +77.5% |
| 2024 | $60.70M | +30.8% |
| 2023 | $46.41M | +143.3% |
| 2022 | $19.08M | +54.6% |
| 2021 | $12.34M | +118.3% |
| 2020 | $5.65M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $107.77M | +77.5% |
| 2024 | $60.70M | +30.8% |
| 2023 | $46.41M | +143.3% |
| 2022 | $19.08M | +54.6% |
| 2021 | $12.34M | +118.3% |
| 2020 | $5.65M | — |